NM_004006.3(DMD):c.5163G>C (p.Lys1721Asn) AND not specified

Clinical significance:Likely benign (Last evaluated: Jan 4, 2021)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_004006.3(DMD):c.5163G>C (p.Lys1721Asn)]

NM_004006.3(DMD):c.5163G>C (p.Lys1721Asn)

DMD:dystrophin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_004006.3(DMD):c.5163G>C (p.Lys1721Asn)
  • NC_000023.11:g.32362950C>G
  • NG_012232.1:g.981660G>C
  • NM_000109.4:c.5139G>C
  • NM_004006.2:c.5163G>C
  • NM_004006.3:c.5163G>CMANE SELECT
  • NM_004009.3:c.5151G>C
  • NM_004010.3:c.4794G>C
  • NM_004011.4:c.1140G>C
  • NM_004012.4:c.1131G>C
  • NP_000100.3:p.Lys1713Asn
  • NP_003997.1:p.Lys1721Asn
  • NP_003997.2:p.Lys1721Asn
  • NP_004000.1:p.Lys1717Asn
  • NP_004001.1:p.Lys1598Asn
  • NP_004002.3:p.Lys380Asn
  • NP_004003.2:p.Lys377Asn
  • LRG_199t1:c.5163G>C
  • LRG_199:g.981660G>C
  • LRG_199p1:p.Lys1721Asn
  • NC_000023.10:g.32381067C>G
Protein change:
dbSNP: rs72468630
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_000109.4:c.5139G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004006.2:c.5163G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004006.3:c.5163G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004009.3:c.5151G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004010.3:c.4794G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004011.4:c.1140G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004012.4:c.1131G>C - missense variant - [Sequence Ontology: SO:0001583]


MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001478695Women's Health and Genetics/Laboratory Corporation of America, LabCorpcriteria provided, single submitter
Likely benign
(Jan 4, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy.

Kong X, Zhong X, Liu L, Cui S, Yang Y, Kong L.

BMC Med Genet. 2019 Aug 14;20(1):139. doi: 10.1186/s12881-019-0873-0.

PubMed [citation]

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001478695.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)


Variant summary: DMD c.5163G>C (p.Lys1721Asn) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0011 in 177459 control chromosomes, predominantly at a frequency of 0.013 within the East Asian subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 1179 fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophinopathies phenotype (1.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.5163G>C has been reported in the literature in at least an individual affected with Dystrophinopathies (e.g. Kong_2019). This report however, does not provide unequivocal conclusions about association of the variant with Dystrophinopathies. Co-occurrence with another likely pathogenic variant has been reported (DMD c.5476G>T, p.E1826X) in our internal database, providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 6, 2021

Support Center